دواء tirzepatide دراسة: تيرزيباتيد يسهم في إنقاص وزن مرضى السكري من النوع الأول

The Potential Indirect Impact of GLP-1 Receptor Agonists in the Management of Fibromyalgia

21.26

★★★★☆4.1 (85)

Oral Semaglutide Approved to Reduce the Risk of Cardiovascular Events

25.07

★★★★★4.6 (60)

A large review of almost 100,000 individuals with fibromyalgia, comparing those who were and were not taking GLP‑1 receptor‑agonists (the same drugs that help with diabetes and weight loss). After matching the

28.58

★★★★★4.2 (160)

First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, GLP-1 & Glucagon triple hormone receptor agonist drug leads to nearly 29% weight loss in first pivotal test! Eli Lilly announced positive topline results from the

20.15

★★★★★4.3 (129)

A large review of almost 100,000 individuals with fibromyalgia, comparing those who were and were not taking GLP‑1 receptor‑agonists (the same drugs that help with diabetes and weight loss). After matching the

28.58

★★★★★4.3 (220)

Weight Loss Injections for Chronic Pain

25.57

★★★★★4.8 (69)

A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings from the

21.18

★★★★★5.0 (299)